Life Sciences
The world of life sciences revolves around a continuous cycle of growth. In-depth specialists, our multi-disciplinary team offers technical, regulatory and transactional expertise throughout the pharmaceutical, agricultural and food sectors. ALTIUS clients include innovators in the pharmaceutical industry as well as hospitals, private equity investors, and leaders in the dental and veterinary segments.
A reputation for excellence
Building on our extensive understanding of the pharmaceutical industry and the daily challenges facing this highly regulated sector, the ALTIUS team guides its clients through complex legislation and, notably, Belgian and EU regulatory compliance issues.
Highly experienced, ALTIUS life sciences legal team represents national and international food, feed and drink producers, agri-biotech companies, plant and animal breeders and industry associations. Considered experts in their respected fields, the ALTIUS life sciences lawyers are frequently active in the Belgian and EU courts and various regulatory organisations.
How we can help
Cell & tissue engineered products
Compliance
Medical devices
Medicinal products’ marketing
Pricing and reimbursement
Protection of plant biotechnological inventions
Our Experts in
Life Sciences Law
Our latest life sciences news
New Mdeon rules applicable as from 1 January 2023
Mdeon, the legally recognised Belgian ethical platform for healthcare professionals and the pharmaceutical industry, announced several new ethics rules applying from 1 January 2023.
Read more
The Belgian Competition Authority fines Novartis for abuse of collective dominance regarding eye disease medicines
The Belgian Competition Authority fines Novartis for abuse of collective dominance regarding eye disease medicines On 23 January 2018, the European Court of Justice (“ECJ”) handed down its judgment (C-179/16) in relation to Novartis’ Lucentis® and Roche’s Avastin® eye disease medicines, and ruled that disseminating misleading information on the off-label use of a medicine could constitute a restriction of competition ‘by object’. Exactly 5 years later, on 23 January 2023, the Belgian Competition Authority (“BCA”) imposed a fine on Novartis Pharma SA and Novartis AG (together “Novartis”) for abuse of collective dominance resulting from disseminating misleading information regarding risks in relation to the off label use of Roche’s Avastin®.
Read more
When are IP holders liable for enforcing a later invalidated IP right?
At this IP Update, our IP specialists, Christophe Ronse and Kirian Claeyé, will discuss under what circumstances IP holders may be held liable for enforcing a later invalidated IP right.
Read moreBrussels Finest Lawyers
At ALTIUS, we look at your business from two different angles: legal
practice and industry sector. Our teams of specialised lawyers are
additionally grouped into dedicated, cross-specialty, industry-focused
teams. Whether you are looking for a dedicated legal specialist or a
team of industry insiders, at ALTIUS, we got your legal issue covered.
Choosing ALTIUS
as your Legal Partner
means…
At ALTIUS, we believe business is always personal. That’s why we’re so much more than just great lawyers; we are team players and relationship builders. Combining legal excellence with passion, optimism, and good judgement, we bring a fresh perspective and genuine commitment. Whatever your legal challenges, we think in new ways and find innovative solutions.